Alnylam Pharmaceuticals shares owned by Campbell & Co. Investment Adviser
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Campbell & Co. Investment Adviser
from 13F filings
Historical chart of Campbell & Co. Investment Adviser investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Alnylam Pharmaceuticals by Campbell & Co. Investment Adviser
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $5.8M | 13k | 456.00 |
| 2024-12-31 | $4.0M | 17k | 235.31 |
| 2024-03-31 | $1.6M | 11k | 149.45 |
| 2022-09-30 | $512k | 2.6k | 200.16 |
| 2022-06-30 | $808k | 5.5k | 145.82 |
| 2022-03-31 | $466k | 2.9k | 163.39 |
| 2021-09-30 | $245k | 1.3k | 188.46 |
| 2018-06-30 | $266k | 2.7k | 98.41 |
| 2014-12-31 | $645k | 6.7k | 96.96 |
More positions owned by Campbell & Co. Investment Adviser
View all positions for Campbell & Co. Investment Adviser